Peter O'Donnell to Neoadjuvant Therapy
This is a "connection" page, showing publications Peter O'Donnell has written about Neoadjuvant Therapy.
Connection Strength
0.134
-
Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. Clin Genitourin Cancer. 2016 12; 14(6):511-517.
Score: 0.090
-
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med. 2026 Apr 02; 394(13):1257-1269.
Score: 0.045